01.23.2014 - By CMG |Advice Like Investing Podcasts, Stock Market, InvestTalk, Mad Money, P
http://gmcstockpicks.com Proprietary algorithms at work. Click here for our free newsletter: http://goo.gl/APYNVJ . This is a review of an undervalued stock in the Healthcare Sector and Medical Instruments and Supplies Industry. Low priced stocks to buy. We do not look at penny stocks. Stock options are a safer bet than penny stocks.
Like us on Facebook: https://www.facebook.com/gmconner14
Follow us on Twitter: https://twitter.com/gmcstockpicks
Add us to your circles on Google Plus: https://plus.google.com/u/0/+Gmcstockpicks/posts
Subscribe to our podcast on iTunes: https://itunes.apple.com/us/podcast/value-momentum-gmc-stock-picks/id737369520?mt=2
Listen and subscribe to our podcast on Stitcher Radio: http://www.stitcher.com/podcast/value-momentum-gmc-stock-picks?refid=stpr
Transcript Below:
Everyone Mathis Conner here with Conner management group today is Thursday, January 23, 2014
0:10
and this week within a look at the best healthcare stock to buy right now I hear the opening
0:16
page we see that the company is in the medical instruments and supplies industry and we see
0:23
its 12 month upside potential at 15.7% on to the second slide and we see that the name
0:32
of his company's copayment next ticker symbol H a E was given the name is Haman net access
0:42
HAE MON DTIC asked and you have the right on this company just hundred billion dollars
0:49
is not a household name but we think it's interesting opportunity as will describe the
0:56
following slide so Haman and its diminishing human antics Corporation engages in the design
1:04
development manufacture and marketing of automated blood component collection devices and surgical
1:10
blood salvage devices the United States and internationally it provides various plasma
1:15
products including Pete PCS brand plasma collection equipment and consumables plasma collection
1:22
containers and intravenous solutions swells information technology platforms for plasma
1:29
customers to manage their donors operations and supply chain so basically human that is
1:35
manufactures devices related to the collection of blood processing applied and also equipment
1:44
related to delivery of public website is HAE 8H 80 MON ET ICS.com says triple W Haman and
1:57
ask.com at their headquarters is in Braintree Massachusetts the company was founded in 1971
2:05
they have 3563 employees once again the ticker symbol is HAE there in healthcare sector their
2:15
specific industry is medical instruments and supplies headaches revenues the last 12 months
2:23
totaled $553 million still visible Smallman some some low was we look at the past there
2:31
net income of the last 12 months totaled 30 $31 million and net cash from operation last
2:39
12 months totaled $94 million market capitalization Haman X right now set to $.15 billion on to
2:50
their products and services slide we got a couple of pictures here we've got there logo
2:59
spelling at Haman X a blow that's the scummy blood management company we has couple excerpts
3:06
from the website one is in with their Haman X prize the reduce costs increase revenue
3:13
with says our new donation product is introducing our new whole blood technologies µ and helping
3:22
hospitals and has patient care and manage costs and United you got pictures of "woman
3:32
writing on electronic tablet another technician on Dr. taking one's blood pressure and another
3:41
looks like a bunch of doctors doing surgery I will send a picture of their corporate headquarters
3:48
selected to three started rebuilding and Braintree Massachusetts and we also have pictures of
3:57
the top two executives a picture of Brian Concannon their president and CEO and a picture
4:04
of Peter Allen their president of global global plasma and going on to Summit metrics annual
4:13
revenues the last 12 months for the again $953 million net income $31 million and the
4:20
cash from operations of the last 12 months totaled $94 million taking a look at the operating
4:28
margins headaches operating margins for 2012 was 21.9% after 2013 it's been tracking to
4:39
be 26% so that's a nice increase an and margins and its related to and acquisition that they
4:48
made and 2012 trailing P/E ratio right now is at 69.6 that is unusually high and then
5:00
you sometimes see distortions like that be because of acquisitions and if you can is
5:07
best try to find another source that it will restate that P/E ratio on in on apples apples
5:16
basis but as it stands at the U the trailing P/E ratio set 69.6 to forward P/E ratios at
5:24
16.8 of the paid ratios at 1.5 note not not too high the prices sales at 2.3 also unnecessarily
5:35
high and the price of books at 2.7 and the enterprise value to either.is at 14.6 Bevins
5:45
this getting up a bit high that last one looking at the recent closing price for Haman excessively
5:54
the company close at $41.70 52-week low the company was $37.71 and 52 week high was $45.90
6:10
so the price of the stock right now it's you know basically the middle between it 52-week
6:17
high and the 52-week low of 20 day moving averages at $42.31 the 50 day moving averages
6:25
at $41.94 and the 200 day moving averages at $41.27 so those moving averages are are
6:36
pretty pretty tight so that they Tells you that there hasn't been too much movement as
6:45
of late on in net net basis the average daily trading volume for Haman antics is 334,000
6:53
shares per day data for the company is 0.7 so it is a little less volatile to the market
7:02
on the upside is the downside and the dividend yield is at 0% average dividend payout ratio
7:10
0% Haman antics doesn't pay dividends onto their stock price chart see that around city
7:23
end of February Hemant X was around $40 and the beginning of May drop down to around $38
7:33
and then quickly rose to a high of nearly $46 and late July and then they had a precipitous
7:45
drop from their $46 down to nearly $40 and this happened in late July or early August
7:54
what happened during that period time the their earnings miss of any and that there
8:00
is is quite a bit of pullback the stock bounced around little bit since late July and that
8:08
it declined back down to around 3050 and early November and then increased again past $43
8:17
and its now around $42 so the company's had a little bit of some some upside downs but
8:27
net net over a year ago it since around the the the same price and overall financial statement
8:38
quality of Haman antics is very good the they do they do have some debt and but they do
8:46
have have cash on on hand you know between 150 $200 million in net Morton takes care
8:55
of the debt they have doodad term is as well as the in the working capital demands so the
9:02
vast statements are are in good shape and as we mentioned earlier the operating margins
9:09
are improving substantially increasing from 2122% to 26% and that that's significant a
9:19
change and that's related to and acquisition and needed in August 2012 inquired a company
9:26
called while they quietly transfuse the transmission business from Monica McCall Paul Corporation
9:33
they been integrating it that into their operations additionally their sales over the past five
9:42
years is relates acquisition but the annual rates of sales last five years of increased
9:48
11.5% per year their earnings are expected to increase over the next year and the they
9:58
also made another acquisition of blues mamas acquisition of another company called and
10:09
Morris medicals SL elects collection systems and that's expected to help their their margins
10:16
increase a bit more so you know that are price private trans week we just saw overall the
10:24
past year you would consider flat the other overall market right now were rarer still
10:33
bears were starting to see some pullbacks from time to time different names has so you
10:41
know there are their some near-term headwinds but we we tend to believe that literally some
10:46
markets correct a very savvy they tend to correct quickly and you know past performance
10:55
is no prediction of future but will see how it goes and those still feeling Haman antics
11:00
is a good opportunity there the recent closing price was $41.70 our model C sees a 12 month
11:11
price target of $40.25 so that gives this opportunity 12 month appreciation potential
11:20
15.7% so imminent this is a company we think he should take a closer look at and is in
11:30
the healthcare industry we know that a lot of changes going on and it is not one of the
11:36
bigger companies that we see some upside potential with this name versus a number of others so
11:45
we feel that this is the best healthcare company to buy right now and all to our last slide
11:55
if you haven't yet the sign up for our Saturday morning newsletter you can get by going to
12:05
www.GMCstockpicks.com you be among the first to hear that great at best opportunities in
12:12
the market are picks are result of our own self developed algorithms where we are reviewing
12:20
and analyzing and ranking over 3500 stocks every week so we feel good about what we been
12:28
doing were new in the block and we can show it was just how good we are so good to our
12:33
website and sign up and that's all we have to this week take care and talk to set